Skip to main content

Advertisement

Table 2 Immunophenotype distribution in 622 cases of mature T-cell and NK-cell lymphoma

From: CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China

Immunophenotype Total [cases (%)] Male/female ratio Age [years, median (range)]
Extranodal NK/T-cell lymphoma, nasal type 317 (51.0) 217/100 43.0 (10–86)
Angioimmunoblastic T-cell lymphoma 118 (19.0) 82/36 63.0 (36–87)
Peripheral T-cell lymphoma, not otherwise specified 81 (13.0) 58/23 49.0 (25–81)
Anaplastic large-cell lymphoma, ALK-positive 31 (5.0) 19/12 21.0 (4–69)
Anaplastic large-cell lymphoma, ALK-negative 15 (2.4) 10/5 45.0 (8–76)
Primary cutaneous, anaplastic large-cell lymphoma    48.0 (24–81)
13 (2.1) 4/9 7.5 (2–13)
Hydroa vacciniforme-like LPD 12 (1.9) 8/4  
Subcutaneous panniculitis-like T-cell lymphoma 12 (1.9) 5/7 36.0 (17–55)
Monomorphic epitheliotropic intestinal T-cell lymphoma 9 (1.4) 6/3 50.0 (38–82)
Hepatosplenic T-cell lymphoma 5 (0.8) 4/1 37.0 (29–44)
Primary cutaneous CD4-positive small/medium T-cell LPD 3 (0.4) 3/0 40.0 (22–60)
Primary cutaneous γδ T-cell lymphoma 2 (0.3) 1/1 19.0 (2–36)
Mycosis fungoides 2 (0.3) 1/1 29.0 (18–40)
Aggressive NK-cell leukemia 2 (0.3) 2/0 27.0 (22–32)
Total 622 420/202 47.5 (2–87)
  1. NK natural killer, ALK anaplastic lymphoma kinase, LPD lymphoproliferative disorder